SXR1096

· Sixera Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SXR1096, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome [Phase 1, Phase 2]